| Aktie | Ticker | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 2.040.650.277 $ | +591.391.118 $ | +50,7 % | 1.449.259.159 $ | +137.666.194 $ | +12,2 % | 1.342.486.545 $ | +12.539.780 $ | +6,3 % | ||
| BANK OF AMERICA CORP /DE/ | BAC | 1.864.412.420 $ | +565.462.109 $ | +43,5 % | 1.298.950.311 $ | +494.540.383 $ | +61,5 % | 804.409.928 $ | -66.060.013 $ | -7,6 % |
| MoonLake Immunotherapeutics | MLTX | 57.404.607 $ | +43.106.387 $ | +301,5 % | 14.298.220 $ | -386.625.707 $ | -96,4 % | 400.923.927 $ | +69.057.447 $ | +20,8 % |
| INSMED Inc | INSM | 47.861.000 $ | -14.063.300 $ | -22,7 % | 61.924.300 $ | +7.578.700 $ | +13,9 % | 54.345.600 $ | +14.293.350 $ | +35,7 % |
| Centessa Pharmaceuticals plc | CNTA | 33.138.250 $ | -13.543.000 $ | -29,0 % | 46.681.250 $ | +19.263.326 $ | +70,3 % | 27.417.924 $ | -5.103.884 $ | -15,7 % |
| JPMORGAN CHASE & CO | JPM | 30.893.580 $ | -1.978.120 $ | -6,0 % | ||||||
| GH Research PLC | GHRS | 16.510.000 $ | -10.895.078 $ | -39,8 % | 27.405.078 $ | +2.909.492 $ | +11,9 % | 24.495.586 $ | +2.331.000 $ | +10,5 % |
| Ascendis Pharma A/S | ASND | 21.324.000 $ | +21.324.000 $ | |||||||
| 2.040.650.277 $ | +591.391.118 $ | +50,7 % | 1.449.259.159 $ | +137.666.194 $ | +12,2 % | 1.342.486.545 $ | +12.539.780 $ | +6,3 % | ||